JD

Jitendra Deviprasad Tiwari

Active Director Director DIN 10921089
DIN 10921089 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jitendra Deviprasad Tiwari

Data last updated:

Jitendra Deviprasad Tiwari is a Director at Unibeck Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 10921089
Primary Designation Director
Industry Pharma
First Appointment 24 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unibeck Pharma Private Limited U46497MH2025PTC438833
Director24 Jan 20252025Active

Board colleagues of Jitendra Deviprasad Tiwari

NameDINCompanyDesignation
Bhupendra Devi Prasad Tiwari10921088Unibeck Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Unibeck Pharma Private Limited
Premium access

Shareholding and investment profile for Jitendra Deviprasad Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendra Deviprasad Tiwari

Jitendra Deviprasad Tiwari currently holds 1 directorship: Unibeck Pharma Private Limited (Director, since 24 Jan 2025).

Jitendra Deviprasad Tiwari was first appointed on 24 Jan 2025 as Director at Unibeck Pharma Private Limited.

The current boards of Jitendra Deviprasad Tiwari's companies include Bhupendra Devi Prasad Tiwari (Unibeck Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available